See more : Concraft Holding Co., Ltd. (4943.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Bellevue Life Sciences Acquisition Corp. (BLACU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bellevue Life Sciences Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- GVIC Communications Corp. (GCT.TO) Income Statement Analysis – Financial Results
- NervGen Pharma Corp. (NGEN.V) Income Statement Analysis – Financial Results
- Taiwan IC Packaging Corporation (3372.TWO) Income Statement Analysis – Financial Results
- TEGNA Inc. (TGNA) Income Statement Analysis – Financial Results
- Jiangsu NandaSoft Technology Company Limited (8045.HK) Income Statement Analysis – Financial Results
Bellevue Life Sciences Acquisition Corp. (BLACU)
About Bellevue Life Sciences Acquisition Corp.
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.83M | 35.39K | 3.31K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.83M | 35.39K | 3.31K | 23.81K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.83M | 35.39K | 3.31K | 23.81K |
| Cost & Expenses | 1.83M | 35.39K | 3.31K | 23.81K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.78M | 228.49K | 236.56K | 206.30K |
| EBITDA | 944.59K | -35.39K | -3.31K | -23.81K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.83M | -35.39K | -3.31K | -23.81K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 2.78M | 0.00 | 0.00 | -2.00 |
| Income Before Tax | 944.59K | -35.39K | -3.31K | -23.81K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 540.81K | -228.48K | -236.56K | -206.30K |
| Net Income | 403.78K | -35.39K | -3.31K | -23.81K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.07 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.07 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 5.62M | 9.06M | 7.93M | 7.89M |
| Weighted Avg Shares Out (Dil) | 5.62M | 9.06M | 7.93M | 7.89M |
Source: https://incomestatements.info
Category: Stock Reports